Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following list is of consultations and invitations to make submissions which are relevant to health and medical research and/or health policy in Australia. Research Australia may not participate in every one however the list is updated regularly.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia at greg.mullins@researchaustralia.org or on (03) 9662 9420.

Consultation Details
REVIEW OF AUSTRALIAN RESPONSIBLE RESEARCH CODE

Due 28 February

The Australian Code for the Responsible Conduct of Research guides institutions and researchers in responsible research practices by setting the required standards, and provides advice on managing departures from these standards.

The NHMRC, ARC and UA are proposing to streamline the Code into a principles-based document that will be supported by guides that provide advice and requirements for implementation of the Code.

The draft principles-based Code and the first draft Guide have been released for public consultation as the first stage of an ongoing process.

SENATE COMMUNITY AFFAIRS LEGISLATION COMMITTEE INQUIRY: THERAPEUTIC GOODS AMENDMENT (2016 MEASURES NO. 1) BILL 2016

Due 3 March

 

Measures in the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 include replacing approvals with notifications for some minor changes, allowing approved Australian organisations to perform some compliance tasks currently only performed in Australia by the TGA and a faster approval process for ‘breakthrough’ medical devices and therapeutics.

The Bill has been referred to the Senate Community Affairs Legislation Committee for inquiry and report. Submissions can be made until 3 March, and the Committee is due to report by 27 March 2017.

Draft National Health Genomics Policy Framework

Due 8 March

 

 

The Commonwealth Department of Health is seeking feedback on the draft National Health Genomics Policy Framework (the Framework).

The Framework is a commitment between Commonwealth and states and territories to work collaboratively to integrate genomics into the health system over time.

While focused on the use of genomics in healthcare it potentially has implications for genomic research.

TGA CONSULTATION: REGULATORY FRAMEWORK FOR COMPLEMENTARY MEDICINES

Due 28 March

The TGA is itself undertaking two consultations in relation to its operations arising from the Sansom Review.

The first relates to the regulatory framework for complementary medicines, including:

·       the development of a three-tiered risk-based framework for their regulation;

·       a list of permitted indications which must be used by the lowest risk complementary medicines;

·       allowing sponsors to claim that their medicine has been assessed by the TGA for efficacy where that medicine has undergone pre-market assessment by the TGA; and

·       mechanisms to incentivise innovation for the complementary medicines sector.

TGA CONSULTATION: IMPROVINGACCESS TO UNAPPROVED THERAPEUTIC GOODS

Due 29 March

 

The second TGA consultation involves proposals to improve access to unapproved therapeutic goods via changes to the Special Access Scheme and the Authorised Prescriber Scheme, with the aims of decreasing duplication and streamlining access to unapproved therapeutic goods which are considered to have an established history of use.
FUNDING FOR RESEARCH INTO CANCERS WITH LOW SURVIVAL RATES

 Due 31 March

The Select Committee into Funding for Research into Cancers with Low Survival Rates will inquire and report on the impact of health research funding models on the availability of funding for research into cancers with low survival rates.